CLINICAL TRIAL

Treatment for Obesity, Morbid

Class III
Waitlist Available · 18+ · Female · Long Beach, CA

This study is evaluating whether a particular type of skin closure is better than another type of skin closure for obese women.

See full description

About the trial for Obesity, Morbid

Eligible Conditions
Obesity, Morbid · Obesity, Severe · Cesarean Sections

Treatment Groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Control Group 1
Stainless steel staples
DEVICE
Control Group 2
Absorbable subcuticular suture
DEVICE

Eligibility

This trial is for female patients aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Women > 18 years old undergoing cesarean delivery
BMI of >/= 40 kg/m2 as determined by height and weight reported during their admission
Live gestation 23 weeks or greater
Women who are able to follow-up 7-14 days after hospital discharge for a visual wound check..
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Within 2 weeks postpartum
Screening: ~3 weeks
Treatment: Varies
Reporting: Within 2 weeks postpartum
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Within 2 weeks postpartum.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 1 primary outcome and 2 secondary outcomes in patients with Obesity, Morbid. Measurement will happen over the course of Within 6 weeks postpartum.

Composite Wound complication
WITHIN 6 WEEKS POSTPARTUM
Rate of wound complications defined as composite wound complication, which includes infection requiring antibiotics, hematoma, seroma, separation or disruption, and/or readmission to the hospital for wound concerns.
WITHIN 6 WEEKS POSTPARTUM
Patient pain score
WITHIN 2 WEEKS POSTPARTUM
Patients' pain associated with their wound within 7-14 days after hospital discharge.
WITHIN 2 WEEKS POSTPARTUM
Patient satisfaction with wound healing
WITHIN 2 WEEKS POSTPARTUM
Patients' satisfaction with the healing of their wound within 7-14 days after hospital discharge.
WITHIN 2 WEEKS POSTPARTUM

Who is running the study

Principal Investigator
J. M.
Jennifer McNulty, MD
MemorialCare Health System

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can obesity, morbid be cured?

Recent findings suggest that morbid obesity does not necessarily result in more severe symptoms, such as obstructive sleep apne and dyslipidemia, as well as decreased quality of life, when compared to morbidly obese who underwent weight-loss surgery. However, obese people who were satisfied with more extreme obesity-induced symptoms may not be content with their symptoms. For this purpose, obesity-surgery should not be considered as only cure for obese symptoms. Recent findings imply that weight control, including weight loss, is a necessary prerequisite for obese patients with symptoms to be satisfied.

Anonymous Patient Answer

What are common treatments for obesity, morbid?

Patients are treated more often with medical therapy than with surgery, while obesity is commoner in whites than in Asian Indians. Weight loss occurs less in Asians than in whites and Hispanics. The majority of obese patients in South-East Asians present for treatment in the secondary care setting and thus there are few inpatient services. We propose that all physicians should be aware of the common methods of treatment for obesity.

Anonymous Patient Answer

What is obesity, morbid?

There is growing evidence that overweight and obesity are associated with an increased risk of cardiovascular disease, hypertension, type 2 diabetes, osteoarthritis, asthma, sleep apnea, and other chronic illnesses. In addition, these associations appear to be most pronounced in men and may be partially genetically determined. In a recent study, findings reinforces the importance of obesity and overweight as risk factors for chronic diseases.

Anonymous Patient Answer

What causes obesity, morbid?

Obesity and morbidity are frequently associated and are closely linked to many common disorders and diseases. As morbid obesity is more strongly and directly associated with diabetes, hypertension, heart disease, stroke and cancer, there is a need to develop targeted obesity prevention and treatment programmes.

Anonymous Patient Answer

How many people get obesity, morbid a year in the United States?

While overall obesity has declined over time, there is currently an increasing prevalence of moderate hypercholesterolemia and of diabetes and other comorbidities. In the past 30 years, the prevalence of obesity and obesity-related comorbidities have increased.

Anonymous Patient Answer

What are the signs of obesity, morbid?

Signs of obesity range from fatigue and difficulty in standing up to loss of appetite, weight loss, difficulty in swallowing, a small waist, and increased abdominal fat. Morbid obesity can be defined as having two or more of the obesity signs outlined here and a high fasting serum triglyceride level.

Anonymous Patient Answer

How does treatment work?

There is currently no cure for HPV. The treatment must be taken under the condition of the patients' health. For example, overweight individuals should take an antiviral drug in an initial treatment phase to slow down the tumor growth, and a medication for lowering the body weight in addition to maintenance therapy. Physicians should also check blood levels of cancer markers and take blood measurements under a proper schedule. For patients with high levels of lipids in their blood, doctors should take care to diminish their intake of triglycerides, fatty foods, and other kinds of fats.

Anonymous Patient Answer

Is treatment safe for people?

There was no clear risk of complications with any of the treatments; however, the results of the study are expected to help the health professionals assess treatment for morbid obesity and assist in treating their patients with care and advice to ensure patient compliance at all times.

Anonymous Patient Answer

What does treatment usually treat?

Patients with obesity or morbid obesity often have comorbidities that can be treated with medications. For example, weight loss alone is not an effective measure for treatment of hypertension or elevated cholesterol levels. Physicians using the ADA and the ACC/AHA recommendations would not treat patients with obesity solely for weight loss. Further research is needed to determine whether specific clinical management strategies have a positive impact on patient-reported health and quality of life and if they are cost-effective.

Anonymous Patient Answer

Is treatment typically used in combination with any other treatments?

About 45% of patients in this study received some form of weight-loss treatment. Weight-loss interventions could be combined with other treatments, however, further investigation is warranted. Obesity remains one of the major challenges for many medical specialties.

Anonymous Patient Answer

Does treatment improve quality of life for those with obesity, morbid?

Treatment of obesity with weight loss and a low-fat diet may improve physical function and some aspects of health related QoL in a patient with morbid obesity. However, the degree of improvement was modest and most aspects of health related QoL were not improved. Weight reduction may be an important component of more comprehensive treatment for morbid obesity.

Anonymous Patient Answer

Have there been any new discoveries for treating obesity, morbid?

Obesity has been a challenge in the health care system since its epidemic in the late 1970s, and this challenge has persisted during these recent years. However, obesity remains a major problem in the health care system. There are currently few new therapies available to treat obesity, morbid, for this problem.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Obesity, Morbid by sharing your contact details with the study coordinator.